Dental Stem Cells Treat Stroke

July 2014
Australasian Science;Jul/Aug2014, Vol. 35 Issue 6, p14
The article reports on a research performed by the University of Adelaide's Centre for Stem Cell Research which investigates the potential of dental stem cells to be used as a therapy for stroke.


Related Articles

  • Stroke promise. Coghlan, Andy // New Scientist;6/1/2013, Vol. 218 Issue 2919, p6 

    The article discusses a study by researcher John Sinden and colleagues at the stem cell research firm ReNeuron of a clinical trial of the effectiveness of stem cell therapy in improving mobility in stroke patients, including walking, lifting limbs, and grasping objects.

  • The potential benefit of stem cell therapy after stroke: an update. Banerjee, Soma; Williamson, Deborah A.; Habib, Nagy; Chataway, Jeremy // Vascular Health & Risk Management;2012 Part 2, Vol. 8, p569 

    Stroke is a leading cause of death and disability worldwide. Stem cell therapy is an emerging therapeutic modality with evidence of significant benefits in preclinical stroke models. A number of phase I and II clinical trials have now been completed, with several more currently under way....

  • Elements: in this month’s issue. Donnelly, Seamas C. // QJM: An International Journal of Medicine;Apr2014, Vol. 107 Issue 4, p249 

    No abstract available.

  • A review of novel optical imaging strategies of the stroke pathology and stem cell therapy in stroke. Aswendt, Markus; Adamczak, Joanna; Tennstaedt, Annette // Frontiers in Cellular Neuroscience;Aug2014, Vol. 8, p1 

    Transplanted stem cells can induce and enhance functional recovery in experimental stroke. Invasive analysis has been extensively used to provide detailed cellular and molecular characterization of the stroke pathology and engrafted stem cells. But post mortem analysis is not appropriate to...

  • Stem cells for neonatal stroke- the future is here. van Velthoven, Cindy T. J.; Gonzalez, Fernando; Vexler, Zinaida S.; Ferriero, Donna M. // Frontiers in Cellular Neuroscience;Jul2014, p1 

    The article focuses on the treatment of neonatal stroke by stem cell therapy. Topics discussed include potential of stem cell therapy in treating neonatal ischemic brain injury, several stem and progenitor cell populations used in neural stem cells, embryonic stem cells, and human umbilical cord...

  • Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: a pilot study. Prasad, Kameshwar; Mohanty, Sujata; Bhatia, Rohit; Srivastava, M. V. P.; Garg, Ajay; Srivastava, Achal; Goyal, Vinay; Tripathi, Manjari; Kumar, Amit; Bal, Chandrashekar; Vij, Aarti; Mishra, Nalini Kant // Indian Journal of Medical Research;Aug2012, Vol. 136 Issue 2, p221 

    Background & objectives: Bone marrow mononuclear cell therapy has emerged as one of the option for the treatment of Stroke. Several preclinical studies have shown that the treatment with mononuclear cell (MNCs) can reduce the infarct size and improve the functional outcome. We evaluated the...

  • Societal Value of Stem Cell Therapy in Stroke - A Modeling Study. Svensson, Johanna; Ghatnekar, Ola; Lindgren, Arne; Lindvall, Olle; Norrving, Bo; Persson, Ulf; Kokaia, Zaal // Cerebrovascular Diseases;Jun2012, Vol. 33 Issue 6, p532 

    Background: Stroke is one of the major causes of disability in the adult population and represents a heavy social and economic burden. Currently available therapeutic tools to support the recovery of impaired brain functions are quite limited. Animal studies have demonstrated that neuronal...

  • FDA designation 'really big deal' for Athersys. COUTRÉ, LYDIA // Crain's Cleveland Business;5/29/2017, Vol. 38 Issue 22, p0004 

    The article reports that biotechnology company Atherys Inc. received a federal designation to enable it to push through with a Phase 3 clinical trial for its stroke treatment. Topics discussed include the Fas Track Designation awarded by the U.S. Food and Drug Administration (FDA) to expedite...

  • Role of neural precursor cells in promoting repair following stroke. Dibajnia, Pooya; Morshead, Cindi M // Acta Pharmacologica Sinica;Jan2013, Vol. 34 Issue 1, p78 

    Stem cell-based therapies for the treatment of stroke have received considerable attention. Two broad approaches to stem cell-based therapies have been taken: the transplantation of exogenous stem cells, and the activation of endogenous neural stem and progenitor cells (together termed neural...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics